Who invested in Phage Pharm?
Phage Pharm's investors include Morningside Group.
Funding summaryUpdated 26 Oct 2026
$13Mraised across 1 round since 2023, from 1 source
Phage Pharm's investors include Morningside Group.
Phage Pharm has raised $13M across 1 round since 2023.
Phage Pharm's most recent round was a Series B of $13M in Mar 2023.
Its most recent round, $13M in Mar 2023, is also its largest on record.
Phage Pharm's first round on record, in Mar 2023, was backed by Morningside Group.
Phage Pharm's latest named round is a Series B, in Mar 2023.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.